Current Treatment Options in Oncology

Papers
(The TQCC of Current Treatment Options in Oncology is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Lessons Learned in Managing Patients with Colorectal Cancer During the COVID-19 Pandemic89
Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer65
Correction to: Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead65
Role of Metastasis-Directed Therapy in Genitourinary Cancers64
The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL)62
An Update on Temporal Bone Paragangliomas53
Antibody-Drug Conjugates for Melanoma and Other Skin Malignancies48
Clinical Application of Artificial Intelligence for Non-melanoma Skin Cancer47
Advances in the Pathogenesis, Diagnosis, Treatment, and Prognosis of Marginal Zone Lymphoma46
Current Approaches of Immune Checkpoint Therapy in Chronic Lymphocytic Leukemia42
“Off-the-Shelf” Allogeneic CAR Cell Therapy—Neglected HvG Effect42
Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes40
Chronic Lymphocytic Leukemia: Chemotherapy Free and Other Novel Therapies Including CAR T37
HPV as a Carcinomic Driver in Head and Neck Cancer: a De-escalated Future?36
Approach to Localized Squamous Cell Cancer of the Esophagus35
Combining Radiotherapy with Immunotherapy in Cervical Cancer: Where Do We Stand and Where Are We Going?34
Recent Advances in Liver Transplantation for Hepatocellular Carcinoma33
Depression and Long-Term Prescription Opioid Use and Opioid Use Disorder: Implications for Pain Management in Cancer33
The Role of Nursing in the Delivery of Cardio-Oncology33
Small Cell Lung Cancer—An Update on Chemotherapy Resistance29
Enhanced Photodynamic Therapy by Improved Light Energy Capture Efficiency of Porphyrin Photosensitizers28
Management of Fatigue in Patients with Advanced Cancer28
Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer27
Targets Selection for Precision Therapy of Relapsed/Refractory Multiple Myeloma: the Latest Advancements25
Reshaping Treatment Paradigms for Advanced Renal Cell Cancer Patients and Improving Patient Management24
The Review of Modified Intersphincteric Resection in the Treatment of Ultra-Low Rectal Cancer24
Where Are We Now and Where Might We Be Headed in Understanding and Managing Brain Metastases in Colorectal Cancer Patients?24
Regorafenib for the Treatment of Sarcoma24
Advances in Targeted Therapy for Metastatic Prostate Cancer24
Current Practice in Carcinoid Heart Disease and Burgeoning Opportunities23
Proposals for Clinical Trials in Chronic Myelomonocytic Leukemia23
Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma: from Bench to Bedside?23
Recognition and Management of the Long-term Effects of Cranial Radiation22
Gastric Cancer with Sarcopenia: an Area Worth Focusing On22
Novel Approaches for the Treatment of Patients with Richter’s Syndrome21
New Treatment Options for Newly-Diagnosed and Relapsed Chronic Lymphocytic Leukemia21
Steroid Premedication and Monoclonal Antibody Therapy: Should We Reconsider?21
Response Evaluation of Neoadjuvant Therapies in Sarcoma20
Essential Thrombocythemia in Adolescents and Young Adults: Clinical Aspects, Treatment Options and Unmet Medical Needs20
How to Sequence Therapies in Mycosis Fungoides20
Optimal Strategies for Colorectal Cancer Screening20
A Comprehensive Review on the Role of Lurbinectedin in Soft Tissue Sarcomas20
R0 Resection in Recurrent Gynecologic Malignancy: Pelvic Exenteration and Beyond19
Promising Blood-Based Biomarkers for Melanoma: Recent Progress of Liquid Biopsy and Its Future Perspectives19
Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors19
Evolution of Treatment Strategies for Gestational Trophoblastic Neoplasia: Chemotherapy, Immunotherapy, and Molecular Targeted Therapy19
Novel Estrogen Receptor-Targeted Agents for Breast Cancer19
Application of Engineered Dendritic Cell Vaccines in Cancer Immunotherapy: Challenges and Opportunities19
Correction to: The Microbiome: the Link to Colorectal Cancer and Research Opportunities19
Treatment Options for Brain Metastases19
Neoadjuvant and Adjuvant Therapy Approaches to Gastric Cancer19
How to Sequence Therapies in Diffuse Large B-Cell Lymphoma Post-CAR-T Cell Failure19
Treating Chronic Pain with Buprenorphine—The Practical Guide18
Approach to Stereotactic Body Radiotherapy for the Treatment of Advanced Hepatocellular Carcinoma in Patients with Child-Pugh B-7 Cirrhosis18
Research Progress on Ferroptosis in Multiple Myeloma18
Contemporary Review of Adenocarcinoma of the Cervix17
Therapeutic Challenges in the Management of Serous Endometrial Intraepithelial Carcinoma (SEIC)17
New Therapeutic Targets in RAS Wild-type Pancreatic Cancer17
Current Trends in Precision Medicine and Next-Generation Sequencing in Head and Neck Cancer17
New PET Radiotracers for the Imaging of Neuroendocrine Neoplasms17
Review of Bone Metastasis in Gynecologic Malignancies: Evaluation and Treatment17
Updates in Breast Cancer Screening and Diagnosis16
Progress in the Treatment of Small Intestine Cancer16
The Dilemma of Treating Delirium: the Conundrum of Drug Management16
New Developments in Systemic Management for High-Risk Early-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer16
What are the Optimal Systemic Treatment Options for Rhabdomyosarcoma?16
One Size Fits Some: Approaching Rare Malignancies of the Urinary Tract16
Updates in Management of Malignant Pleural Mesothelioma16
Management of Laryngeal Dysplasia and Early Invasive Cancer16
How Genetics Can Drive Initial Therapy Choices for Older Patients with Acute Myeloid Leukemia16
Neoadjuvant Photodynamic Therapy: An Updated Therapeutic Approach for Non-Melanoma Skin Cancers15
Taxane-Associated Acute Pain Syndrome: a Review of its Features and Management15
A Review on Integrating Breast Cancer Clinical Data: A Unified Platform Perspective15
Perioperative Chemotherapy for Liver Metastasis of Colorectal Cancer: Lessons Learned and Future Perspectives15
Non-chemotherapy Options for Newly Diagnosed Mantle Cell Lymphoma15
New Insights into the Understanding of Mechanisms of Radiation-Induced Heart Disease15
Treatment of Non-Small Cell Lung Cancer with Atypical EGFR Mutations15
Complex Persistent Opioid Dependence—an Opioid-induced Chronic Pain Syndrome14
Targeting the Renin–angiotensin–aldosterone System (RAAS) for Cardiovascular Protection and Enhanced Oncological Outcomes: Review14
Hypnosis for Symptom Management in Adult Cancer Patients: What is the Evidence?14
Optimal First-Line Therapy for Metastatic Adenocarcinoma of the Esophagus14
Advances in PSMA-Targeted Radionuclide Therapeutics14
“When Less is More”: Paradigm Shifts in Radiation Treatment for Early-Stage Breast Cancer14
Correction to: Cardiotoxicity of Systemic Melanoma Treatments14
Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom Management13
The Role of Induction Therapy for Sinonasal Cancers13
Enhancing Colorectal Cancer Treatment Through VEGF/VEGFR Inhibitors and Immunotherapy13
New Developments in Treating RAS-Mutated Metastatic Colorectal Cancer13
The Role of SIRT1 in Leukemia13
Advancements in Melanoma Therapies: From Surgery to Immunotherapy12
Correction to: Voluntary Assisted Dying/Euthanasia: Will This Have an Impact on Cancer Care in Future Years?12
Myxoid Liposarcomas: Systemic Treatment Options12
Correction to: Recent Advances in Succinate Dehydrogenase Deficient Gastrointestinal Stromal Tumor Systemic Therapies12
Management and Treatment of Non-small Cell Lung Cancer with MET Alteration and Mechanisms of Resistance12
Extent of Resection and Outcomes of Patients with Primary Malignant Brain Tumors12
ctDNA to Guide Treatment of Colorectal Cancer: Ready for Standard of Care?12
The Use of Targeted Agents in the Treatment of Gynecologic Cancers12
Re-thinking the Role of Thoracic Radiotherapy in the First-Line Treatment for Extensive-Stage Small Cell Lung Cancer12
Radiotherapy for Advanced Esophageal Cancer: from Palliation to Curation11
Immunotherapy for Metastatic Triple Negative Breast Cancer: Current Paradigm and Future Approaches11
Cardio-Oncology Care Delivered in the Non-academic Environment11
Immune Checkpoint Inhibitors and Chemoradiation for Limited-Stage Small Cell Lung Cancer11
RAS and Other Molecular Targets in Pancreatic Cancer: The Next Wave Is Coming11
Management of Functional Pancreatic Neuroendocrine Neoplasms11
Correction to: Surgical Management and Considerations for Patients with Localized High-Risk Prostate Cancer11
Therapeutic Management of Malignant Wounds: An Update11
HER2-Positive Metastatic Colorectal Cancer11
Neuroendocrine Tumors: Germline Genetics and Hereditary Syndromes11
Systemic Management of Advanced Adrenocortical Carcinoma11
Prediction of Response to FDA-Approved Targeted Therapy and Immunotherapy in Acute Lymphoblastic Leukemia (ALL)10
The Improving Outcomes in Relapsed-Refractory Diffuse Large B Cell Lymphoma: The Role of CAR T-Cell Therapy10
Targeted Therapy in Early Stage Non-small Cell Lung Cancer10
Measurable Residual Disease in Chronic Lymphocytic Leukemia: Current Understanding and Evolving Role in Clinical Practice10
Diagnosis and Treatment of Myxoid Liposarcoma10
Advanced Acral Melanoma Therapies: Current Status and Future Directions10
Impact of PSMA PET on Prostate Cancer Management10
Is There Still a Role for Transplant for Patients with Mantle Cell Lymphoma (MCL) in the Era of CAR-T Cell Therapy?10
Systemic and Targeted Therapies in Adenoid Cystic Carcinoma10
Community Palliative Care: What are the Best Models?10
The Role of Pharmacogenomics in Opioid Prescribing10
Current WHO Guidelines and the Critical Role of Genetic Parameters in the Classification of Glioma: Opportunities for Immunotherapy10
Integrating Systemic Therapies into the Multimodality Therapy of Patients with Craniopharyngioma10
Nanomedicine-Based Treatments for Rare and Aggressive Ocular Cancers: Advances in Drug Delivery10
Innovations in Cardio-oncology Resulting from the COVID-19 Pandemic10
What Clinical Trials Are Needed for Treatment of Leiomyosarcoma?10
Osteogenic Sarcoma of the Head and Neck: Is Chemotherapy Needed?10
0.063499927520752